Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A [Phase 1, Phase 2]

View source ↗

Summary

This is an ongoing Phase 1/2 clinical trial evaluating NXT007 in adults with Hemophilia A, assessing safety, tolerability, pharmacokinetics, pharmacodynamics, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• NXT007

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hemophilia A | Phase 1, Phase 2 | Status: RECRUITING